Antibiotics Aren’t Profitable Enough for Big Pharma to Make More

10 May 2019

Public health experts are calling for new incentives to reward companies for bringing drugs that are effective against resistant strains to market.

Further reading: Bloomberg

OUR UNDERWRITERS

Unrestricted financial support by:

	Antimicrobial Resistance Fighter Coalition
	Bangalore Bioinnovation Centre
	INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS
	BD

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!